MYNZ Competitors & Alternatives
Compare Mainz Biomed N.V. Ordinary Shares with similar stocks in the same industry
Pharmaceutical Preparations
MYNZ
Main Stock$0.84
Tradestie Score
52
Market Cap
$7.14M
Revenue Growth
-0.4%
Analyst Upside
+1558.6%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$931.09
|
$739.95B | 40.8 | 58 | Compare |
|
JNJ
Johnson & Johnson
|
$238.41
|
$448.07B | 22.0 | 62 | Compare |
|
ABBV
ABBVIE INC.
|
$206.37
|
$431.71B | 88.5 | 57 | Compare |
|
NVO
Novo-Nordisk A/S
|
$36.91
|
$262.92B | 10.4 | 61 | Compare |
|
AZN
AstraZeneca PLC
|
$200.81
|
$261.56B | 31.2 | 61 | Compare |
|
NVS
Novartis AG
|
$151.22
|
$254.99B | 21.5 | 58 | Compare |
|
ABT
Abbott Laboratories
|
$101.83
|
$232.30B | 27.7 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$119.28
|
$225.13B | 16.6 | 62 | Compare |
|
PFE
Pfizer Inc.
|
$27.10
|
$154.70B | 20.8 | 60 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$46.83
|
$121.27B | 20.6 | 61 | Compare |
More MYNZ Analysis
Data updated: Apr 07, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry